Literature DB >> 17357383

The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose.

Karthikeyan Kanagarajan1, Jeanna M Marraffa, Nicole C Bouchard, Padmanabhan Krishnan, Robert S Hoffman, Christine M Stork.   

Abstract

Treatment of hypotension caused by calcium channel blocker overdose (CCB) remains a challenge. We describe the successful use of vasopressin in two patients with massive CCB overdoses in whom hypotension was unresponsive to calcium, glucagon, insulin, and conventional vasopressor therapies. While various modes of treatments have been used to treat the hypotension of CCB overdose, this is the first report to our knowledge of the successful use of vasopressin in this clinical setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17357383     DOI: 10.1080/15563650600795669

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  5 in total

Review 1.  Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies.

Authors:  Andis Graudins; Hwee Min Lee; Dino Druda
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

2.  Inhibition of soluble epoxide hydrolase as a novel approach to high dose diazepam induced hypotension.

Authors:  Arzu Ulu; Bora Inceoglu; Jun Yang; Vikrant Singh; Stephen Vito; Heike Wulff; Bruce D Hammock
Journal:  J Clin Toxicol       Date:  2016-05-30

3.  Toxic bradycardias in the critically ill poisoned patient.

Authors:  Melissa L Givens
Journal:  Emerg Med Int       Date:  2012-04-01       Impact factor: 1.112

4.  A multifaceted approach to calcium channel blocker overdose: a case report and literature review.

Authors:  Robert Burkes; Gregg Wendorf
Journal:  Clin Case Rep       Date:  2015-05-18

Review 5.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.